跳至主要内容
临床试验/NCT03023085
NCT03023085已完成1 期

A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects

Braintree Laboratories1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2016年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
120
试验地点
1
主要终点
Number and Percentage of Subjects With Successful Bowel Cleansing

研究概览

简要总结

The objective of this study is to evaluate the safety and efficacy of BLI4700 as a bowel preparation prior to colonoscopy in adult patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female outpatients who are undergoing colonoscopy for a routinely accepted indication.
  • Have previously had a colonoscopy performed
  • At least 18 years of age
  • Subjects must be scheduled for a morning colonoscopy (prior to 12:00PM)
  • If female, and of child-bearing potential, is using an acceptable form of birth control.
  • Negative urine pregnancy test at screening, if applicable
  • In the Investigator's judgment, subject is mentally competent to provide informed consent to participate in the study

排除标准

  • Subjects with known or suspected ileus, severe ulcerative colitis, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or megacolon.
  • Subjects who had previous significant gastrointestinal surgeries.
  • Subjects with uncontrolled pre-existing electrolyte abnormalities, or those with clinically significant electrolyte abnormalities based on Visit 1 laboratory results.
  • Subjects with a prior history of renal, liver or cardiac insufficiency
  • Subjects with impaired consciousness that predisposes them to pulmonary aspiration.
  • Subjects undergoing colonoscopy for foreign body removal and/or decompression.
  • Subjects who are pregnant or lactating, or intending to become pregnant during the study.
  • Subjects of childbearing potential who refuse a pregnancy test.
  • Subjects allergic to any preparation components.
  • Subjects who, in the opinion of the Investigator, should not be included in the study for any reason, including inability to follow study procedures.
  • Subjects who have participated in an investigational surgical, drug, or device study within the past 30 days.

研究组 & 干预措施

BLI4700

Experimental

BLI4700 Bowel Preparation

干预措施: BLI4700 (Drug)

结局指标

主要结局

Number and Percentage of Subjects With Successful Bowel Cleansing

时间窗: Day of colonoscopy

% of subjects with successful bowel preparation rated by blinded colonoscopist on a 4 point scale (1=poor, 2=fair, 3=good, 4 = excellent)

次要结局

未报告次要终点

研究者

发起方
Braintree Laboratories
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Pilot Evaluation of BLI4700 Bowel Preparation in... | 临床试验